All Stories

  1. Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis
  2. A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis
  3. Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape
  4. In reply
  5. MTBDRplusand MTBDRslAssays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis
  6. Nosocomial transmission of multidrug-resistant tuberculosis
  7. Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations
  8. Out-patient MDR-TB care in Moldova
  9. Transmission ofmycobacterium tuberculosisUral 163-15 lineage causing multidrug-resistant tuberculosis among hospitalized patients
  10. Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis
  11. Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing
  12. Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates
  13. Combined Antigen-Specific Interferon-γ and Interleukin-2 Release Assay (FluoroSpot) for the Diagnosis of Mycobacterium tuberculosis Infection
  14. Multidrug-Resistant Tuberculosis in Europe, 2010–2011
  15. Prognostic significance of novel katG mutations in Mycobacterium tuberculosis
  16. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage
  17. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates
  18. The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis
  19. Evaluation of Pyrosequencing for Detecting Extensively Drug-Resistant Mycobacterium tuberculosis among Clinical Isolates from Four High-Burden Countries
  20. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
  21. High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova
  22. Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay
  23. Predicting Extensively Drug-Resistant Mycobacterium tuberculosis Phenotypes with Genetic Mutations
  24. Geographical Differences Associated with Single-Nucleotide Polymorphisms (SNPs) in Nine Gene Targets among Resistant Clinical Isolates of Mycobacterium tuberculosis
  25. Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova
  26. Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country
  27. First Evaluation of an Improved Assay for Molecular Genetic Detection of Tuberculosis as Well as Rifampin and Isoniazid Resistances
  28. Assessment Of The Nosocomial Transmission Of MDR TB In Moldova Using DNA Fingerprinting Of M.tuberculosis